BMEA vs EMN
Biomea Fusion Inc (BMEA) versus Eastman Chemical Company (EMN) — a side-by-side from cached financials, not a winner call.
Biomea Fusion Inc (BMEA) is a biotechnology company listed on US.
Eastman Chemical Company (EMN) is a specialty chemicals company listed on US.
BMEA does not have a complete income-statement cache yet.
Latest reported EMN revenue for 2024-12-31 was $9.38B. Net income was $908.0M. Revenue was up 1.9% from 2023-12-31 to 2024-12-31. EMN currently screens at market cap $8.21B and trailing P/E 20.8.
BMEA currently screens at market cap $94.7M. EMN currently screens at market cap $8.21B and trailing P/E 20.8.
Not investment advice. Open the BMEA and EMN stock pages for the full models.
Not investment advice.